SAA1 and glioma: By contrast, we found that the gene expression levels of SAA1 in brain tumors were associated with glioma malignancy and patient mortality at threshold 25 (Fig. 5A–C), and that high levels of SAA1 were specifically associated with the mortality of patients with the proneural type (Fig. 5D).